OpenAlex
PricingAboutJobs
Log inGet started
Work

Dapagliflozin preferentially reduces fibrosis biomarkers in chronic heart failure patients with high extracellular matrix remodeling activity

HTML

Year: 2026
Type: article
Source: European Journal of Heart Failure
DOI: 10.1093/ejhf/xuag193.173
Authors: R Muniz-Anquela, E Angeli, A Riquelme-Perez, V Martinez-Pina, M T Perez-Martinez, C Anagnostopoulos, M Karsdal, F Genovese, M Domingo, H Morillas, J Nunez, M Cobos-Marcos, J A Noguera, A Bayes-Genis, D Pascual Figal
Institutions: Hospital Universitario Virgen de la Arrixaca, Nordic Bioscience (Denmark), Hospital Universitari Germans Trias i Pujol, Hospital Clínica Benidorm, Hospital Clínico Universitario de Valencia, Hospital Universitario Puerta de Hierro Majadahonda
Language: English

Topic: Cardiac Fibrosis and Remodeling
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: dapagliflozin, chronic heart failure, myocardial fibrosis, extracellular matrix remodeling, PRO-C3, PRO-C6, collagen cross-linking, fibrosis biomarkers, SGLT2 inhibitors, inflammatory markers, NT-proBNP, P1NP, renal function
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W7166468601
FWCI:
Cites:
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms